Crossmark

Anti‐tumor effects of <scp>PIM</scp> / <scp>PI</scp> 3K/ <scp>mTOR</scp> triple kinase inhibitor <scp>IBL</scp> ‐302 in neuroblastoma

Crossref DOI link: https://doi.org/10.15252/emmm.201810058

Published Online: 2019-07-16

Published Print: 2019-08

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Mohlin, Sofie https://orcid.org/0000-0002-2458-3963
Hansson, Karin

Radke, Katarzyna

Martinez, Sonia https://orcid.org/0000-0003-2230-7794
Blanco‐Apiricio, Carmen

Garcia‐Ruiz, Cristian https://orcid.org/0000-0003-2914-7914
Welinder, Charlotte

Esfandyari, Javanshir

O'Neill, Michael

Pastor, Joaquin

von Stedingk, Kristoffer

Bexell, Daniel https://orcid.org/0000-0001-9426-9550
Funding

Funding for this research was provided by:

Vetenskapsrådet

Cancerfonden

Barncancerfonden

Region Skåne

Magnus Bergvalls Stiftelse

Crafoordska Stiftelsen

Jeanssons Stiftelser

Berth von Kantzows Stiftelse

Ministerio de Ciencia e Innovación (CIT‐090000‐2008‐14)
License Information

Version of Record valid from 2019-07-16
More Information

Publication History

Received: 2018-11-12

Accepted: 2019-06-24

Published: 2019-07-16